2407 — Gaush Meditech Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSuper Stock

Annual cashflow statement for Gaush Meditech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	149	-138	-275	248	155
Depreciation
Amortisation
Non-Cash Items	41.9	420	541	39.4	63.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-73.4	-177	-97.3	-114	-193
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	130	164	234	249	108
Capital Expenditures	-1.82	-28	-48	-45.6	-81.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-996	108	-88	-122	99.8
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-998	79.8	-136	-168	18.5
Financing Cash Flow Items	-2.17	-86.7	-42.5	-46.3	-33.9
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	856	72.8	3.08	-190	-303
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-25.3	302	113	-103	-197